Clinicians and researchers have suspected for years that an aggressive, less-common form of multiple sclerosis (MS) is likely a distinct form of the disease. Now, new research conducted using a more ...

Researchers have clarified how B cells and T helper 17 cells drive experimental autoimmune encephalomyelitis, a mouse ...

Please provide your email address to receive an email when new articles are posted on . The model predicted MS diagnosis with 91.5% specificity and non-MS diagnosis with 100% specificity. However, it ...

Multiple sclerosis (MS) has long been regarded as a disease with different subtypes such as "relapsing" or "progressive." An international study, published on August 20, 2025, in Nature Medicine under ...

Multiple sclerosis (MS) has long been regarded as a disease with different subtypes such as “relapsing” or “progressive.” An international study, published on August 20, 2025, in Nature Medicine under ...

Please provide your email address to receive an email when new articles are posted on . A machine-learning model produced 46,644 estimated scores on a disability scale from 3,404 scores. Application ...

To provide the right treatment for MS, it is important to know when the disease changes from relapsing-remitting to secondary progressive, a transition that is currently recognized on average three ...

An investigational drug for multiple sclerosis from Io Therapeutics has restored leg mobility and myelin nerve coatings in mice, the biotech announced Dec. 23. The Texas-based company conducted the ...

I am eager to see our ultimate goal realized—to change the lives of MS patients and future generations by identifying the cause of, and a cure for, this disease.” — Dr. Saud A. Sadiq, founder and ...